Biolase Profit Margin 2010-2023 | BIOL

Current and historical gross margin, operating margin and net profit margin for Biolase (BIOL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Biolase net profit margin as of December 31, 2023 is -41.97%.
Biolase Annual Profit Margins
Biolase Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.005B $0.049B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.394B 19.11
Becton Dickinson (BDX) United States $66.895B 19.43
West Pharmaceutical Services (WST) United States $26.385B 47.05
Cardinal Health (CAH) United States $25.104B 15.09
Align Technology (ALGN) United States $23.254B 44.92
Cooper (COO) United States $17.657B 26.72
Labcorp (LH) United States $16.691B 14.40
Henry Schein (HSIC) United States $9.396B 16.25
DENTSPLY SIRONA (XRAY) United States $6.339B 16.70
Merit Medical Systems (MMSI) United States $4.284B 24.51
Patterson (PDCO) United States $2.309B 11.06
STAAR Surgical (STAA) United States $2.307B 72.25
CONMED (CNMD) United States $2.025B 18.37
Atrion (ATRI) United States $0.695B 35.81
Lifevantage (LFVN) United States $0.080B 12.89
Pro-Dex (PDEX) United States $0.066B 24.91